![[PDF]](/pb-assets/Icons/adobe-pdf-icon-1498649896243.png){kind=icon}
Abstract
Background:
Histopathological studies have revealed four different immunopathological patterns of lesion pathology in early multiple sclerosis (MS). Pattern II MS is characterised by immunoglobulin and complement deposition in addition to T-cell and macrophage infiltration and is more likely to respond to plasma exchange therapy, suggesting a contribution of autoantibodies.
Objective:
To assess the frequency of anti-myelin oligodendrocyte glycoprotein (MOG), anti-M1-aquaporin-4 (AQP4), anti-M23-AQP4, anti-N-methyl-d-aspartate-type glutamate receptors (NMDAR) and 25 other anti-neural antibodies in pattern II MS.
Methods:
Thirty-nine serum samples from patients with MS who had undergone brain biopsy (n = 24; including 13 from patients with pattern II MS) and from histopathologically non-classified MS patients (n = 15) were tested for anti-MOG, anti-M1-AQP4, anti-M23-AQP4, anti-NMDAR, anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor-type glutamate receptors (AMPAR), anti-gamma-aminobutyric acid receptors (GABABR), anti-leucine-rich, glioma-activated protein 1 (LGI1), anti-contactin-associated protein 2 (CASPR2), anti-dipeptidyl-peptidase-like protein-6 (DPPX), anti-Tr/Delta/notch-like epidermal growth factor–related receptor (DNER), anti-Hu, anti-Yo, anti-Ri, anti-Ma1/Ma2, anti-CV2/collapsin response mediator protein 5 (CRMP5), anti-glutamic acid decarboxylase (GAD), anti-amphiphysin, anti-Ca/RhoGTPase-activating protein 26 (ARHGAP26), anti-Sj/inositol-1,4,5-trisphosphate receptor 1 (ITPR1), anti-Homer3, anti-carbonic anhydrase–related protein (CARPVIII), anti-protein kinase gamma (PKCgamma), anti-glutamate receptor delta 2 (GluRdelta2), anti-metabotropic glutamate receptor 1 (mGluR1) and anti-mGluR5, as well as for anti-glial nuclei antibodies (AGNA) and Purkinje cell antibody 2 (PCA2).
Keywords
Multiple sclerosis, biopsy, histopathology, neuropathology, pattern II, autoantibodies, complement, aquaporin-4, myelin oligodendrocyte glycoprotein, N-methyl-d-aspartate type glutamate receptors, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor-type glutamate receptors, metabotropic gamma-aminobutyric acid receptors, voltage-gated potassium channels, contactin-associated protein 2, leucine-rich, glioma-activated protein 1, dipeptidyl-peptidase-like protein-6
References
| 1. |
Lucchinetti, C, Bruck, W, Parisi, J. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann Neurol 2000; 47: 707–717. Google Scholar | Crossref | Medline | ISI |
| 2. |
Keegan, M, Konig, F, McClelland, R. Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet 2005; 366: 579–582. Google Scholar | Crossref | Medline | ISI |
| 3. |
Jarius, S, Ruprecht, K, Wildemann, B. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflammation 2012; 9: 14. Google Scholar | Crossref | Medline | ISI |
| 4. |
Reindl, M, Di Pauli, F, Rostasy, K. The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol 2013; 9: 455–461. Google Scholar | Crossref | Medline | ISI |
| 5. |
Jarius, S, Wildemann, B, Paul, F. Neuromyelitis optica: Clinical features, immunopathogenesis and treatment. Clin Exp Immunol 2014; 176: 149–164. Google Scholar | Crossref | Medline | ISI |
| 6. |
Levy, M, Wildemann, B, Jarius, S. Immunopathogenesis of neuromyelitis optica. Adv Immunol 2014; 121: 213–242. Google Scholar | Crossref | Medline | ISI |
| 7. |
Bruck, W, Popescu, B, Lucchinetti, CF. Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate. Ann Neurol 2012; 72: 385–394. Google Scholar | Crossref | Medline | ISI |
| 8. |
Kuhlmann, T, Lassmann, H, Bruck, W. Diagnosis of inflammatory demyelination in biopsy specimens: A practical approach. Acta Neuropathol 2008; 115: 275–287. Google Scholar | Crossref | Medline | ISI |
| 9. |
Mader, S, Gredler, V, Schanda, K. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflammation 2011; 8: 184. Google Scholar | Crossref | Medline | ISI |
| 10. |
Titulaer, MJ, Hoftberger, R, Iizuka, T. Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis. Ann Neurol 2014; 75: 411–428. Google Scholar | Crossref | Medline | ISI |
| 11. |
Saadoun, S, Waters, P, Owens, GP. Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain. Acta Neuropathol Commun 2014; 2: 35. Google Scholar | Crossref | Medline | ISI |
| 12. |
Balint, B, Jarius, S, Nagel, S. Progressive encephalomyelitis with rigidity and myoclonus: A new variant with DPPX antibodies. Neurology 2014; 82: 1521–1528. Google Scholar | Crossref | Medline | ISI |
| 13. |
Stoeck, K, Carstens, PO, Jarius, S. Prednisolone and azathioprine are effective in DPPX antibody–positive autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm 2015; 2: e86. Google Scholar | Crossref | Medline |
| 14. |
Jarius, S, Wildemann, B. ‘Medusa head ataxia’: The expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook. J Neuroinflammation 2015; 12: 168. Google Scholar | Crossref | Medline | ISI |
| 15. |
Probst, C, Komorowski, L, de Graaff, E. Standardized test for anti-Tr/DNER in patients with paraneoplastic cerebellar degeneration. Neurol Neuroimmunol Neuroinflamm 2015; 2: e68. Google Scholar | Crossref | Medline |
| 16. |
Jarius, S, Wandinger, KP, Horn, S. A new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: Immunological characterization. J Neuroinflammation 2010; 7: 21. Google Scholar | Crossref | Medline | ISI |
| 17. |
Jarius, S, Martinez-Garcia, P, Hernandez, AL. Two new cases of anti-Ca (anti-ARHGAP26/GRAF) autoantibody-associated cerebellar ataxia. J Neuroinflammation 2013; 10: 7. Google Scholar | Crossref | Medline | ISI |
| 18. |
Jarius, S, Wildemann, B. ‘Medusa head ataxia’: The expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC. J Neuroinflammation 2015; 12: 167. Google Scholar | Crossref | Medline | ISI |
| 19. |
Doss, S, Nümann, A, Ziegler, A. Anti-Ca/anti-ARHGAP26 antibodies associated with cerebellar atrophy and cognitive decline. J Neuroimmunol 2014; 267: 102–104. Google Scholar | Crossref | Medline | ISI |
| 20. |
Jarius, S, Scharf, M, Begemann, N. Antibodies to the inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) in cerebellar ataxia. J Neuroinflammation 2014; 11: 206. Google Scholar | Crossref | Medline | ISI |
| 21. |
Jarius, S, Wildemann, B. ‘Medusa-head ataxia’: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII. J Neuroinflammation 2015; 12: 166. Google Scholar | Crossref | Medline | ISI |
| 22. |
Jarius, S, Probst, C, Borowski, K. Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen. J Neurol Sci 2010; 291: 52–56. Google Scholar | Crossref | Medline | ISI |
| 23. |
Jarius, S, Franciotta, D, Bergamaschi, R. NMO-IgG in the diagnosis of neuromyelitis optica. Neurology 2007; 68: 1076–1077. Google Scholar | Crossref | Medline | ISI |
| 24. |
Jarius, S, Franciotta, D, Paul, F. Testing for antibodies to human aquaporin-4 by ELISA: Sensitivity, specificity, and direct comparison with immunohistochemistry. J Neurol Sci 2012; 320: 32–37. Google Scholar | Crossref | Medline | ISI |
| 25. |
Jarius, S, Paul, F, Franciotta, D. Mechanisms of Disease: Aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol 2008; 4: 202–214. Google Scholar | Crossref | Medline |
| 26. |
Jarius, S, Wildemann, B. AQP4 antibodies in neuromyelitis optica: Diagnostic and pathogenetic relevance. Nat Rev Neurol 2010; 6: 383–392. Google Scholar | Crossref | Medline | ISI |
| 27. |
Lucchinetti, CF, Mandler, RN, McGavern, D. A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica. Brain 2002; 125: 1450–1461. Google Scholar | Crossref | Medline | ISI |
| 28. |
Genain, CP, Cannella, B, Hauser, SL. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat Med 1999; 5: 170–175. Google Scholar | Crossref | Medline | ISI |
| 29. |
Zamvil, SS, Slavin, AJ. Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder? Neurol Neuroimmunol Neuroinflamm 2015; 2: e62. Google Scholar | Crossref | Medline |
| 30. |
Kale, N, Pittock, SJ, Lennon, VA. Humoral pattern II multiple sclerosis pathology not associated with neuromyelitis Optica IgG. Arch Neurol 2009; 66: 1298–1299. Google Scholar | Crossref | Medline |
| 31. |
Jarius, S, Wildemann, B. Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: A critical review of the literature. Brain Pathol 2013; 23: 661–683. Google Scholar | Crossref | Medline | ISI |
| 32. |
Konig, FB, Wildemann, B, Nessler, S. Persistence of immunopathological and radiological traits in multiple sclerosis. Arch Neurol 2008; 65: 1527–1532. Google Scholar | Crossref | Medline |
| 33. |
Spadaro, M, Gerdes, LA, Mayer, MC. Histopathology and clinical course of MOG-antibody-associated encephalomyelitis. Ann Clin Transl Neurol 2015; 2: 295–301. Google Scholar | Crossref | Medline | ISI |
| 34. |
Waters, P, Jarius, S, Littleton, E. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol 2008; 65: 913–919. Google Scholar | Crossref | Medline |
| 35. |
Jarius, S, Wandinger, KP, Borowski, K. Antibodies to CV2/CRMP5 in neuromyelitis optica-like disease: Case report and review of the literature. Clin Neurol Neurosurg 2012; 114: 331–335. Google Scholar | Crossref | Medline | ISI |
| 36. |
Mayer, MC, Breithaupt, C, Reindl, M. Distinction and temporal stability of conformational epitopes on myelin oligodendrocyte glycoprotein recognized by patients with different inflammatory central nervous system diseases. J Immunol 2013; 191: 3594–3604. Google Scholar | Crossref | Medline | ISI |
| 37. |
Jarius, S, Paul, F, Fechner, K. Aquaporin-4 antibody testing: Direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate. J Neuroinflammation 2014; 11: 129. Google Scholar | Crossref | Medline | ISI |
